--- title: "Brain-Computer Interfaces Finally Have a Price: RMB 900 a Session. That Matters More Than It Sounds" date: 2026-09-01 category: Brain–Computer Interface site: NeuroAI canonical: https://neuroai.site/a/na-bci-gets-a-price-list language: en --- # Brain-Computer Interfaces Finally Have a Price: RMB 900 a Session. That Matters More Than It Sounds > A hospital in Chengdu listed a non-invasive BCI adaptation fee of over RMB 900 — among the first official prices for the technology in China. Without a price, hospitals cannot charge; without charging, they cannot procure. ## Key takeaways - A hospital in **Chengdu** quietly listed a new charge: **non-invasive BCI adaptation fee, over RMB 900 per session** — among the first cities in China to set an official price for the technology. - **Wuhan Yiruide Medical**, which operates the service, is in discussions on clinical cooperation with **West China Hospital** and **Sichuan Provincial People's Hospital**. - On **31 August 2026**, Shenzhen released a draft legislative proposal on BCI industry innovation, proposing to write BCI into the city's science and technology innovation plan. - First-half BCI financing in China **exceeded RMB 7 billion**, more than the whole of the previous year. - A separate first: a **Tianjin**-approved EEG acquisition and cognitive function assessment system became China's first BCI product approved for assisted diagnosis of cognitive impairment. ## Why a price list is a bigger deal than a breakthrough Do not underestimate that price list. Until now, the biggest problem for brain-computer interfaces was not the technology. It was **having no price**. If a hospital cannot charge for something, it cannot procure it — and however good the technology is, it stays in the laboratory. By writing an adaptation fee into its charge catalogue, Chengdu effectively issued the technology a **licence to operate**. A product manager at the company put it plainly: *with a charge catalogue, the technology can genuinely spread through clinical practice.* Then Shenzhen moved on 31 August, publishing a draft legislative proposal on BCI industry development that would write BCI into the city's S&T innovation plan and build it into an innovation source. One city set a price. One city began legislating. The commercial gears started turning. ## Where the technology actually is In plain terms, a BCI is a machine that reads brain electrical activity. There are two kinds: - **Invasive**: electrodes implanted in the brain. The most accurate signal, but it requires opening the skull. - **Non-invasive**: a helmet or cap. No trauma, safe, weaker signal — but sufficient. What is happening clinically is more grounded than people expect: - **Rehabilitation.** Stroke and spinal cord injury patients control a robotic hand by *intending* to move, promoting neural remodelling. - **Early screening.** A Chengdu institution uses wireless dry electrodes to take a five-minute non-invasive EEG reading for early screening of autism and brain development risk in children — already deployed in communities. - **Assisted diagnosis.** A Tianjin-approved EEG acquisition and cognitive function assessment system became China's first BCI product approved for assisted diagnosis of cognitive impairment. ## Money and risk, both worth seeing clearly First-half BCI financing exceeded RMB 7 billion, more than the previous full year. It is busy. Several realities remain unavoidable. **RMB 900 is an adaptation fee, not a treatment fee.** Subsequent rehabilitation training is charged per course, which is not light for an ordinary household. Whether it enters insurance reimbursement is the critical next step. **EEG data is privacy at its most private.** Brain activity is more intimate than a fingerprint or a face. Who stores it, and whether it can be misused, are questions the regulations are still catching up to. **Do not be misled by "mind control" mythology.** Current non-invasive devices are mostly monitoring and training aids. They are a long way from film-style thought-to-action. Be cautious of any consumer product claiming to "read minds" or "control everything." ## What to do now If someone in your family needs stroke rehabilitation, check whether a tertiary hospital near you runs a BCI rehabilitation programme. Earlier intervention produces better outcomes. If you are considering brain development assessment for a child, wait for community-level universal screening to roll out. Do not spend heavily on "EEG toys" in the meantime. If you are watching the sector as an investor, read policy documents rather than news. A price catalogue in Chengdu and legislation in Shenzhen are both industrial starting signals. The bill for brain-computer interfaces has now been printed. The technology is still young — but the price has moved ahead of the technology. ## Honest limitations A single municipal price listing does not imply insurance reimbursement or national adoption. The RMB 7 billion half-year financing total is an aggregate of reported deals and depends on what is counted. Claims about specific products' approved indications should be verified against the regulator's register before clinical decisions are made. *Sources: Chengdu medical service price catalogue; Shenzhen legislative draft (31 August 2026); NMPA approval records; industry financing reports. Information only — not medical or investment advice.* --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-bci-gets-a-price-list Free to quote with attribution and a link to the original.